Schedule 13G ownership disclosure

Sunesis Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 867328700

Event date: 2020-07-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,869,565
Percent of class
6.6500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-20-000108
Form type
SC 13G
Filer
SABBY MANAGEMENT, LLC
CIK
CIK 1535610
Filed
Jul 29, 2020
Reporting period
Jul 29, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub